73 related articles for article (PubMed ID: 29439315)
1. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow microRNA-34a is a good indicator for response to treatment in acute myeloid leukemia.
Abdellateif MS; Hassan NM; Kamel MM; El-Meligui YM
Oncol Res; 2024; 32(3):577-584. PubMed ID: 38361758
[TBL] [Abstract][Full Text] [Related]
3. Serum circRNA_100199 is a Prognostic Biomarker in Acute Myeloid Leukemia.
Yan L; Yan Q
Int J Gen Med; 2023; 16():4661-4668. PubMed ID: 37868816
[TBL] [Abstract][Full Text] [Related]
4. ALOX5AP is a new prognostic indicator in acute myeloid leukemia.
Chen XY; Wen XM; Zhao W; Chu MQ; Gu Y; Huang HH; Yuan Q; Xu ZJ; Qian J; Lin J
Discov Oncol; 2023 Nov; 14(1):210. PubMed ID: 37994961
[TBL] [Abstract][Full Text] [Related]
5. [The Expression of
Li JJ; Wu YP; Zhang MM; Wang M; Zhang PP; Liu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):376-381. PubMed ID: 38660839
[TBL] [Abstract][Full Text] [Related]
6. Dynamic patterns of microRNA expression during acute myeloid leukemia state-transition.
Frankhouser DE; O'Meally D; Branciamore S; Uechi L; Zhang L; Chen YC; Li M; Qin H; Wu X; Carlesso N; Marcucci G; Rockne RC; Kuo YH
Sci Adv; 2022 Apr; 8(16):eabj1664. PubMed ID: 35452289
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-based therapies: Revolutionizing the treatment of acute myeloid leukemia.
Chandraprabha Vineetha R; Anitha Geetha Raj J; Devipriya P; Sreelatha Mahitha M; Hariharan S
Int J Lab Hematol; 2024 Feb; 46(1):33-41. PubMed ID: 38105344
[TBL] [Abstract][Full Text] [Related]
8. LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15.
Zuo W; Zhou K; Deng M; Lin Q; Yin Q; Zhang C; Zhou J; Song Y
Aging (Albany NY); 2020 Oct; 12(19):18970-18981. PubMed ID: 33012724
[TBL] [Abstract][Full Text] [Related]
9. miR-155 as a Biomarker in B-Cell Malignancies.
Due H; Svendsen P; Bødker JS; Schmitz A; Bøgsted M; Johnsen HE; El-Galaly TC; Roug AS; Dybkær K
Biomed Res Int; 2016; 2016():9513037. PubMed ID: 27294145
[TBL] [Abstract][Full Text] [Related]
10. Label-free microfluidic chip for segregation and recovery of circulating leukemia cells: clinical applications in acute myeloid leukemia.
Ouyang D; Ye N; Jiang Y; Wang Y; Hu L; Chao S; Yarmush M; Tuner M; Li Y; Tang B
Biomed Microdevices; 2023 Dec; 26(1):3. PubMed ID: 38085348
[TBL] [Abstract][Full Text] [Related]
11. Expression of immune check point gene TIM-3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome.
Kamal AM; Nabih NA; Elleboudy NS; Radwan SM
Oncol Lett; 2021 Apr; 21(4):325. PubMed ID: 33692857
[TBL] [Abstract][Full Text] [Related]
12. High
Ji G; Yang X; Li J
Open Med (Wars); 2024; 19(1):20240944. PubMed ID: 38584833
[TBL] [Abstract][Full Text] [Related]
13. Correlation between HOX11 Gene Expression and Clinical Prognosis of Patients with Acute Leukemia.
Li L; Ma J; Shen S
Altern Ther Health Med; 2024 Apr; ():. PubMed ID: 38687853
[TBL] [Abstract][Full Text] [Related]
14. Lack of Altered BECN1 Gene Expression in Iranian Patients with Acute Myeloid Leukemia.
Keyvan L; Bidoki SK; Zare Abdollahi D; Mansouri N; Hashemi M; Mortazavi Tabatabaei S; Fardmanesh H; Meimandi M; Ayatollahi SM; Jalaeikhoo H; Movafagh A
Asian Pac J Cancer Prev; 2016 Dec; 17(12):5173-5177. PubMed ID: 28124883
[TBL] [Abstract][Full Text] [Related]
15. Decreased miR-144 expression as a non-invasive biomarker for acute myeloid leukemia patients.
Zhao Q; Li J; Chen S; Shen K; Ai G; Dai X; Xie B; Shi Y; Jiang S; Feng J; Li W
Pharmazie; 2017 Apr; 72(4):232-235. PubMed ID: 29441994
[TBL] [Abstract][Full Text] [Related]
16. Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy.
Mastaglio S; Wong E; Perera T; Ripley J; Blombery P; Smyth MJ; Koldej R; Ritchie D
Blood Adv; 2018 Feb; 2(4):335-346. PubMed ID: 29449224
[TBL] [Abstract][Full Text] [Related]
17. Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.
Schmidt JR; Rücker-Braun E; Heidrich K; von Bonin M; Stölzel F; Thiede C; Middeke JM; Ehninger G; Bornhäuser M; Schetelig J; Schubert K; von Bergen M; Heidenreich F
Proteomes; 2018 Feb; 6(1):. PubMed ID: 29439554
[TBL] [Abstract][Full Text] [Related]
18. miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1.
Zhu L; Yang S; Wang J
Int J Mol Med; 2019 Nov; 44(5):1824-1832. PubMed ID: 31485607
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
Huang Y; Zou Y; Lin L; Ma X; Chen H
Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia.
Zhao C; Wang S; Zhao Y; Du F; Wang W; Lv P; Qi L
J Cell Physiol; 2019 May; 234(5):6161-6172. PubMed ID: 30246348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
